Subsequent studies have found that TNKS inhibitors such as IWR-1, IWR-2, and JW55 can stabilize AXIN and inhibit the proliferation inhibition mediated by Wnt/β-catenin signaling on many types of tumor cells, including colorectal and liver cancer. This evidence concerns the gene TNKS and liver cancer.